Expression of inducible nitric oxide synthase in transplanted rat liver and its inhibitory effect

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 3, 2005, Pages 360-363

  Wang, Guang Yi ^a,b   Meng, Wei ^a   Ji, Bai ^a   Du, Xiao Hong ^a   Zhao, Jun ^a  

^a First Hospital of Jilin University ^*

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Graft rejection; Liver transplantation; Nitric oxide synthase; Rat

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; TACROLIMUS;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; ENZYME INHIBITORS; GRAFT REJECTION; GUANIDINES; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED BN; RATS, INBRED LEW; SEVERITY OF ILLNESS INDEX; TACROLIMUS;

EID: 23944451231     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Varadarajan R, Golden-Mason L, Young L, McLoughlin P, Nolan N, McEntee G, et al. Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation. Transplantation 2004;78:250-256.
2. Selmi C, Zuin M, Biondi ML, Invernizzi P, Battezzati PM, Bernini M, et al. Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity. J Gastroenterol Hepatol 2003;18:1150-1155.
3. Kimura H, Katsuramaki T, Isobe M, Nagayama M, Meguro M, Kukita K, et al. Role of inducible nitric oxide synthase in pig liver transplantation. J Surg Res 2003;111:28-37.
4. Kaibori M, Sakitani K, Oda M, Kamiyama Y, Masu Y, Nishizawa M, et al. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. J Hepatol 1999;30:1138-1145.
5. Martin-Sanz P, Bosca L, Olmedilla L, Perez-Pena J, Garutti I, Sanz J, et al. Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation. Clin Transplant 1999;13:221-230.
6. Sarela AI, Mihaimeed FM, Batten JJ, Davidson BR, Mathie RT. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 1999;44:749-753.
7. An International Panel. Banff schema for grading acute liver allograft rejection: an international concensus document. Hepatology 1997;25:658-663.
8. Martin-Sanz P, Olmedilla L, Dulin E, Casado M, Callejas NA, Perez-Pena J, et al. Presence of methylated arginine derivatives in orthotopic human liver transplantation: relevance for liver function. Liver Transpl 2003;9:40-48.
9. Shah V, Kamath PS. Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl 2003;9:1-11.
10. Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA. Blockade of the L-argjnine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 2002;36:573-581.
11. Meguro M, Katsuramaki T, Nagayama M, Kimura H, Isobe M, Kimura Y, et al. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation 2002;73:1439-1446.
12. Biecker E, Neef M, Sagesser H, Shaw S, Koshy A, Reichen J. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int 2004; 24:345-353.
13. Zanaro NL, Romero MC, Duek F, Imventarza O, Lendoire J, Sassetti B. Nitric oxide in liver transplantation. Clin Chem Lab Med 2001;39:932-936.
14. Romero M, Garcia-Monzon C, Clemente G, Salcedo M, Alvarez E, Majano PL, et al. Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: evidence of modulation by corticosteroids. Liver Transpl 2001;7:16-21.
15. Tox U, Burkhardt MA, Benz C, Arnold JC, Otto G, Theilmann L, et al. Expression of apoptosis and apoptosis-related peptides in various stages of rejection in the human transplanted liver. Hepatogastroenterology 2001;48:1697-1700.
16. Zanaro NL, Romero MC, Duek F, Imventarza O, Lendoire J, Sassetti B. Nitric oxide in liver transplantation. Clin Chem Lab Med 2001;39:932-936.
17. Hon WM, Lee KH, Khoo HE. Nitric oxide in liver diseases: friend, foe, or just passerby? Ann N Y Acad Sci 2002;962: 275-295.
18. Westerholt A, Himpel S, Hager-Gensch B, Maier S, Werner M, Stadler J, et al. Intragraft iNOS induction during human liver allograft rejection depresses cytochrome p450 activity. Transpl Int 2004;Jul 29 [Epub ahead of print]
19. Varadarajan R, Golden-Mason L, Young L, McLoughlin P, Nolan N, McEntee G, et al. Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation. Transplantation 2004;78:250-253.
20. Qu DM. NO and NOS. Physiolopathological Sci Clinic Foreign Med Sci 1997;17:270-271.
21. Tabernero A, Schneider F, Potenza MA, Fidi-Soa Randriamboavonjy V, Chasserot S, Wolf P, et al. Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone. Intensive Care Med 2003;29:262-270.
22. Liang TB, Man K, Kin-Wah Lee T, Hong-Teng Tsui S, Lo CM, Xu X, et al. Distinct intragraft response pattern in relation to graft size in liver transplantation. Transplantation 2003; 75:673-678.
23. Yang H, Majno P, Morel P, Toso C, Triponez F, Oberholzer J, et al. Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 2002;64:94-103.
24. Coito AJ, Buelow R, Shen XD, Amersi F, Moore C, Volk HD, et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 2002;74:96-102.
25. Albornoz L, Motta A, Alvarez D, Estevez A, Bandi JC, McCormack L, et al. Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances. J Hepatol 2001;35;452-256.
26. Omasta AK, Nevens F, Fevery J. Gene therapy to reduce portal hypertension: possible bridge to liver transplantation. Acta Chir Belg 2000;100:288.
27. Carrizo PH, Dubin M, Stoppani AO. Physiopathologic effects of nitric oxide and their relationship with oxidative stress Medicina (B Aires) 1998;58:367-373.
28. Wang K, Deutschman CS, Clemens MG, De Maio A. Reciprocal expression of phosphoenolpyruvate carboxykinase and acute phase genes during acute inflammation. Shock 1995;3: 204-209.
29. Marcinkiewcz J, Grabowska A, Chain B. Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur J immunol 1995;25:947-951.
30. Franco-Gou R, Peralta C, Massip-Salcedo M, Xaus C, Serafin A, Rosello-Catafau J. Protection of reduced-size liver for transplantation. Am J Transplant 2004;4:1408-1420.
31. Yamaguchi Y, Okabe K, Matsumura F, Akizuki E, Matsuda T, Ohshiro H, et al. Peroxynitrite formation during rat hepatic allograft rejection. Hepatology 1999;29:777-784.
32. Uchiyama H, Yanaga K, Kishihara K, Nomoto K, Sugjmachi K. Increased urinary nitrate excretion associated with hepatic allograft rejection in experimental rat models and clinical cases. Transpl Int 2000;13:260-265.
33. Zhang S, He XS. The molecular mechanism of warm ischemia-reperfusion injury in liver graft Zhonghua Gan Zang Bing Za Zhi 2003;11:767-768.
34. Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA. Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 2002;36:573-581.
35. Picard S, Parthasarthy S, Fruebis J, Witztwm JL. Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors. Proc Natl Acad Sci USA 1992;89:6876-6880.
36. Ou P, Wolff SP. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol 1993;46:1139-1144.
37. Diao TJ, Yuan TY, Li YL. Immunologic role of nitric oxide in acute rejection of golden hamster to rat liver xenotransplantation. World J Gastroenterol 2002;8:746-751.
38. Gong JP, Tu B, Wang W, Peng Y, Li SB, Yan LN. Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol 2004;10:73-76.
39. Geller DA, Chia SH, Takahashi Y, Yagnik GP, Tsoulfas G, Murase N. Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation. J Parenter Enteral Nutr 2001;25:142-147.
40. Hongo D, Bryson JS, Kaplan AM, Cohen DA. Endogenous nitric oxide protects against T cell-dependent lethality during graft-versus-host disease and idiopathic pneumonia syndrome. J Immunol 2004;173:1744-1756.